Abstract
A simple and convenient synthesis of (±)-bakuchiol has been developed. The key intermediate was obtained in only one step from the easily available starting material, citral, by an 1,4-addition procedure. (±)-Bakuchiol was finally produced in 4 steps to give 50% overall yield.
Keywords: (±)-Bakuchiol, citral, 1,4-addition, Grignard reagent
Letters in Organic Chemistry
Title: Simple and Convenient Synthesis of (±)-Bakuchiol
Volume: 5 Issue: 6
Author(s): Hongli Chen and Yuanchao Li
Affiliation:
Keywords: (±)-Bakuchiol, citral, 1,4-addition, Grignard reagent
Abstract: A simple and convenient synthesis of (±)-bakuchiol has been developed. The key intermediate was obtained in only one step from the easily available starting material, citral, by an 1,4-addition procedure. (±)-Bakuchiol was finally produced in 4 steps to give 50% overall yield.
Export Options
About this article
Cite this article as:
Chen Hongli and Li Yuanchao, Simple and Convenient Synthesis of (±)-Bakuchiol, Letters in Organic Chemistry 2008; 5 (6) . https://dx.doi.org/10.2174/157017808785740499
DOI https://dx.doi.org/10.2174/157017808785740499 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effects of Limonoid Cedrelone on MDA-MB-231 Breast Tumor Cells in vitro
Anti-Cancer Agents in Medicinal Chemistry Small Regulatory Molecules Acting Big in Cancer: Potential Role of Mito-miRs in Cancer
Current Molecular Medicine Role of P-Glycoprotein in the Intestinal Absorption of Tanshinone IIA, a Major Active Ingredient in the Root of Salvia miltiorrhiza Bunge
Current Drug Metabolism Arginine Deprivation, Autophagy, Apoptosis (AAA) for the Treatment of Melanoma
Current Molecular Medicine Current Evidence from Phase III Clinical Trials of Selenium Supplementation in Critically Ill Patients: Why Should We Bother?
Mini-Reviews in Medicinal Chemistry Development of Furo[2,3-b]quinoline Derivatives with Anti-Breast Cancer Property by Targeting Topoisomerase II
Anti-Cancer Agents in Medicinal Chemistry Biotechnological Production of Statins: Metabolic Aspects and Genetic Approaches
Current Pharmaceutical Biotechnology Nanosystems in Drug Targeting: Opportunities and Challenges
Current Nanoscience Tyrosine Kinases and Inflammatory Signalling
Current Molecular Medicine The Caveolin-1 Connection to Cell Death and Survival
Current Molecular Medicine Transcription Factors in Asthma: Are Transcription Factors a New Target for Asthma Therapy?
Current Drug Targets Box-Behnken Design Optimized TPGS Coated Bovine Serum Albumin Nanoparticles Loaded with Anastrozole
Current Drug Delivery Recombinant Snake Venom Cystatin Inhibits Tumor Angiogenesis in vitro and in vivo Associated with Downregulation of VEGF-A165, Flt-1 and bFGF
Anti-Cancer Agents in Medicinal Chemistry Recent Patents on Live Bacteria and their Products as Potential Anticancer Agents
Recent Patents on Anti-Cancer Drug Discovery HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Inflammatory Network
Inflammation & Allergy - Drug Targets (Discontinued) Current and Next Generation Topical Anti-Skin Cancer Therapeutics
Drug Delivery Letters Recent Advances of MEK Inhibitors and Their Clinical Progress
Current Topics in Medicinal Chemistry Cholinergic Targets in Lung Cancer
Current Pharmaceutical Design Power from the Garden: Plant Compounds as Inhibitors of the Hallmarks of Cancer
Current Medicinal Chemistry Editorial (Thematic Issue: Applications of Peptides in Nanotechnology)
Current Topics in Medicinal Chemistry